Alter Pharma to create 80 new jobs in Dublin

Pharmaceutical company, Alter Pharma, is set to create 80 jobs in Ireland following the opening of its new worldwide headquarters in Dublin.

The planned increase will bring the company’s Irish workforce to 120 by 2018. Alter chief executive, Pierter Van Rompay, said the move underscored his firm’s commitment to growth in the region.
“Opening our new €5 million euro facility underlines our commitment to Ireland and will allow for our rapid expansion plans,” commented Mr Van Rompay. “We look forward to continuing to grow our excellent team here to complement our product portfolio.”
Alter Pharma, which was founded in 2010, has five companies based in Ireland: Generic Specialty Pharma, Generic Pharma International, Beta Active PI Pharma, Steac Pharmaceuticals and Novalus Healthcare.
IDA Ireland, the agency responsible for the attraction and development of Foreign Direct Investment in Ireland, helped Alter Pharma in its initial moves.
IDA chief Martin Shanahan believed generic pharmaceuticals were contributing significantly to overall employment in the sector.
Alter Pharma develops and manufactures generic pharmaceutical drugs in a range of areas such as oncology, cardiology and central nervous system disorders.

Author

Phill Allen

Managing Director

An in and outside the (bioprocess) box thinker, fluid management specialist Phill knows a thing or two about keeping pharma liquid logistics flowing.

Follow me